Hjem › Kardiovaskulær sykdom › Virginia › Arlington
Kliniske studier for Kardiovaskulær sykdom i Arlington, VA
13 studier for Kardiovaskulær sykdom søker deltakere på steder i og rundt Arlington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
ELEVATE-HFpEF Clinical Study
Rekrutterer
- Inova Fairfax Hospital, Falls Church · 4 mi unna
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RekruttererFase 2
- Carient Heart and Vascular LLC-Reston, Reston · 14 mi unna
- Carient Heart & Vascular - Manassas, Manassas · 22 mi unna
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RekruttererFase 3
- Seven Corners Medical Center, Falls Church · 4 mi unna
- Carient Heart and Vascular, Manassas · 22 mi unna
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
RekruttererFase 3
- Virginia Heart, Falls Church · 4 mi unna
Product Surveillance Registry
RekruttererObservasjonsstudie
- Falls Church, Falls Church · 4 mi unna
- Fairfax, Fairfax · 11 mi unna
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RekruttererFase 3
- Clinical Trial Site, Arlington
- Clinical Trial Site, Falls Church · 4 mi unna
- Clinical Trial Site, Fairfax · 11 mi unna
- og 1 flere
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Rekrutterer
- Inova Fairfax Hospital, Fairfax · 11 mi unna
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Rekrutterer
- Inova Fairfax Medical Campus, Falls Church · 4 mi unna
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RekruttererFase 3
- Inova Fairfax Hospital, Falls Church · 4 mi unna
- Virginia Heart, Falls Church · 4 mi unna
- Carient Heart and Vascular, Manassas · 22 mi unna
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RekruttererFase 3
- Research Site, Falls Church · 4 mi unna
- Research Site, Fairfax · 11 mi unna
- Research Site, Manassas · 22 mi unna
- og 1 flere
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RekruttererFase 3
- Virginia Heart, Falls Church · 4 mi unna
- Inova Cardiology - Fairfax, Fairfax · 11 mi unna
- Carient Heart and Vascular, Manassas · 22 mi unna
Global Paradise System US Post Approval Study
RekruttererObservasjonsstudie
- Inova Fairfax Hospital, Fairfax · 11 mi unna
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
RekruttererFase 3
- Virginia Heart, Falls Church · 4 mi unna
Kardiovaskulær sykdom-studier i andre byer
- Boston, MA37 studier
- New York City, NY33 studier
- Washington, DC29 studier
- Houston, TX24 studier
- Dallas, TX23 studier
- Atlanta, GA22 studier
- Cleveland, OH22 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
- Pittsburgh, PA20 studier
- St. Louis, MO20 studier
- San Francisco, CA18 studier
Andre studier i Arlington
- Ikke-småcellet lungekreft104 studier
- Metastatisk kreft53 studier
- Kolorektal kreft52 studier
- Kreft (alle typer)48 studier
- Brystkreft46 studier
- Eggstokkreft46 studier
- Lungekreft41 studier
- Endometriekreft39 studier
- Pankreaskreft33 studier
- Plateepitelcancer i hode og hals26 studier
- Småcellet lungekreft23 studier
- Tripelnegativ brystkreft20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.